Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.58
+0.24 (2.88%)
At close: Mar 27, 2024, 4:00 PM
8.36
-0.22 (-2.56%)
After-hours: Mar 27, 2024, 7:24 PM EDT

MRVI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-119.03220.21182.0488.97-4.47-4.47
Depreciation & Amortization
48.7838.133.5425.8424.0822.35
Share-Based Compensation
34.5918.6710.4624.631.682.12
Other Operating Activities
161.88259142.5312.752.82-20.18
Operating Cash Flow
126.22535.98368.57152.1924.12-0.19
Operating Cash Flow Growth
-76.45%45.42%142.18%531.09%--
Capital Expenditures
-52.69-29.26-14.39.09-17.15-3.61
Acquisitions
-69.62-238.35119.96-3.0200.16
Investing Cash Flow
-122.31-267.61105.666.07-17.15-3.45
Share Issuance / Repurchase
000292.13-0.23-0.01
Debt Issued / Paid
-5.77-5.44-6187.63-2.6448.72
Other Financing Activities
-55.32-182.06-153.05-426.55-1.3-57.88
Financing Cash Flow
-61.09-187.5-159.0553.21-4.17-9.17
Exchange Rate Effect
00-0.090.020.03-0.07
Net Cash Flow
-57.1880.87315.09211.482.83-12.87
Free Cash Flow
73.54506.71354.27161.286.97-3.8
Free Cash Flow Growth
-85.49%43.03%119.66%2214.90%--
Free Cash Flow Margin
25.45%57.39%44.33%56.77%4.87%-3.07%
Free Cash Flow Per Share
0.563.853.0915.580.03-0.01
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).